GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Price-to-Free-Cash-Flow

2cureX AB (OSTO:2CUREX) Price-to-Free-Cash-Flow : N/A (As of Dec. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Price-to-Free-Cash-Flow?

As of today (2024-12-11), 2cureX AB's share price is kr0.412. 2cureX AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was kr-1.77. Hence, 2cureX AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for 2cureX AB's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 9 years, 2cureX AB's highest Price-to-Free-Cash-Flow Ratio was 152.51. The lowest was 11.36. And the median was 78.72.

OSTO:2CUREX's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 36.58
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

2cureX AB's Free Cash Flow per Share for the three months ended in Jun. 2024 was kr0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-1.77.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -25.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -150.90% per year.

During the past 9 years, 2cureX AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 70.70% per year. The lowest was -508.00% per year. And the median was -25.90% per year.


2cureX AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for 2cureX AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Price-to-Free-Cash-Flow Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

2cureX AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of 2cureX AB's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, 2cureX AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2cureX AB's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where 2cureX AB's Price-to-Free-Cash-Flow falls into.



2cureX AB Price-to-Free-Cash-Flow Calculation

2cureX AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.412/-1.773
=N/A

2cureX AB's Share Price of today is kr0.412.
2cureX AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.77.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

2cureX AB  (OSTO:2CUREX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


2cureX AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


2cureX AB Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB Headlines

No Headlines